A CD10‐negative adult B‐lymphoblastic leukaemia with amplification of KMT2A without rearrangement: A case report and review of the English literature

Documenti analoghi

• Monocytic transition in B‐lymphoblastic leukaemia with a DUX4 rearrangement
  di: Jingwei Li, et al.
  Pubblicazione: (2026)
• Epigenetic dysregulation and therapeutic targeting of RET receptor tyrosine kinase in high‐risk KMT2A ‐rearranged acute myeloid leukaemia
  di: Arundhati Chavan, et al.
  Pubblicazione: (2025)
• Improvement in cutaneous disease with menin inhibitor monotherapy in KMT2A rearranged AML
  di: John Chadwick, et al.
  Pubblicazione: (2025)
• The integration of blinatumomab consolidation in the CALGB 10403 regimen for adults with B‐cell precursor acute lymphoblastic leukaemia in measurable residual disease‐negative remission
  di: Jose Tinajero, et al.
  Pubblicazione: (2025)
• Quadriparesis after CD19 × CD22 bicistronic chimeric antigen receptor T cells for B‐cell acute lymphoblastic leukaemia
  di: Alexander W. Rankin, et al.
  Pubblicazione: (2025)